Restless legs syndrome caused by quetiapine successfully treated with ropinirole in 2 patients with bipolar disorder

Journal of Clinical Psychopharmacology

Volumn 28, Issue 6, 2008, Pages 704-705

  Urbano, Maria R ^a   Ware, J Catesby ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CARBAMAZEPINE; CLONAZEPAM; LORAZEPAM; OXCARBAMAZEPINE; QUETIAPINE; ROPINIROLE; UNCLASSIFIED DRUG; DIBENZOTHIAZEPINE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; INDOLE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; BEDTIME DOSAGE; BIPOLAR DISORDER; CASE REPORT; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; LETTER; LOW DRUG DOSE; PRIORITY JOURNAL; RATING SCALE; RESTLESS LEGS SYNDROME; SLEEP DISORDER; TREATMENT RESPONSE; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; DOPAMINE AGONISTS; FEMALE; HUMANS; INDOLES; MIDDLE AGED; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME;

EID: 59049106445     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31818b2764     Document Type: Letter

References (14)

1. Physicians Desk Reference. 2008. Montvale, NJ: Thomas Healthcare Inc; 2007:670.
2. Goldstein JM. Quetiapine fumarate (Sero-quel): a new atypical antipsychotic. Drugs Today. 1999;35:193-210.
3. Timdahl K, Carlsson A, Stening G. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms. Hum Psychopharmacol. 2007;22:315-325.
4. Cortese L, Caligiuri MP, Williams R, et al. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia. J Clin Psychopharmacol. 2008;28:69-73.
5. Ferini-Strambi L. RLS-like symptoms: differential diagnosis by history and clinical assessment. Sleep Med. 2007;8:S3-S6.
6. Hening WA, Allen RP. Restless legs syndrome (RLS): the continuing development of diagnostic standards and severity measures. Sleep Med. 2003;4:95-97.
7. Gamaldo CE, Earley CJ. Restless legs syndrome: a clinical update. Chest. 2006;130:1596-1604.
8. Kraus T, Schuld A, Pollmacher T. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol. 1999;19;478-479.
9. Page RL, Ruscin JM, Bainbridge JL, et al. Restless legs syndrome induced by escitalo- pram: case report and review of the literature. Pharmacotherapy. 2008;28:271-280.
10. Pinninti NR, Rajnish M, Townsend J, et al. Periodic restless legs syndrome associated with quetiapine use: a case report. J Clin Psychopharmacol. 2005;25:617-618.
11. Wetter TC, Brunner J, Bronisch T. Restless legs syndrome probably induced by risperi- done treatment. Pharmacopsychiatry. 2002; 35:109-111.
12. Kikukawa S. Effectiveness of aripiprazole in treatment of adults with attention deficit disorder and restless legs syndrome. Int J Neuropsychopharmacol. 2008;11:439-440.
13. Bogan RK. Ropinirole treatment for restless legs syndrome. Expert Opin Pharmacother. 2008;9:611-23.
14. Hafeez ZH, Kalinowski CM. Sonambulism induced by quetiapine: two case reports and a review of the literature. CNS Spectr. 2007;12: 910-912.